SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

Thomas A. Zelniker, Stephen D. Wiviott, Itamar Raz, Kyungah Im, Erica L. Goodrich, Marc P. Bonaca, Ofri Mosenzon, Eri T. Kato, Avivit Cahn, Remo H.M. Furtado, Deepak L. Bhatt, Lawrence A. Leiter, Darren K McGuire, John P.H. Wilding, Marc S. Sabatine